Not Medicare Enrolled
Dr. Mark Segal, MD
Medical Oncology · Columbus, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Segal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Segal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Segal
Dr. Mark Segal is a medical oncology specialist in Columbus, OH, with 21 years of NPI registration. Based on federal Medicare data, Dr. Segal performed 5,691 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Segal received a total of $10,726 from 94 pharmaceutical and/or device companies across 555 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Segal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 20% volume in OH
$10,726 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,691
Medicare services
Top 20% in OH for medical oncology
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,857 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
734 | $8 | $29 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
554 | $0 | $1 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
381 | $61 | $277 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
331 | $89 | $390 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
202 | $8 | $9 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
182 | $11 | $67 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
56 | $91 | $421 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
41 | $75 | $210 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $115 | $509 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
38 | $20 | $103 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
35 | $8 | $26 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
32 | $156 | $741 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
31 | $5 | $17 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
30 | $46 | $374 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
27 | $47 | $208 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
23 | $99 | $406 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
22 | $5 | $16 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
22 | $11 | $66 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $134 | $595 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
18 | $38 | $117 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
16 | $61 | $214 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
2.1% high complexity
64.6% medium
33.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,726
Total received (2018-2024)
Avg $1,532/year across 7 years
Top 27% in OH for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
94
Companies
555
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,700
2023
$2,743
2022
$1,744
2021
$879
2020
$635
2019
$500
2018
$524
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$298
Merck Sharp & Dohme LLC
$223
Eisai Inc.
$217
AstraZeneca Pharmaceuticals LP
$208
Astellas Pharma US Inc
$182
PFIZER INC.
$159
Daiichi Sankyo Inc.
$151
Incyte Corporation
$135
Takeda Pharmaceuticals U.S.A., Inc.
$132
SOBI, INC
$126
SEAGEN INC.
$100
Celgene Corporation
$99
Genentech USA, Inc.
$97
JAZZ PHARMACEUTICALS INC.
$91
BeiGene USA, Inc.
$83
GlaxoSmithKline, LLC.
$81
Pharmacosmos Therapeutics Inc.
$73
EMD Serono, Inc.
$72
Lilly USA, LLC
$69
Gilead Sciences, Inc.
$65
Regeneron Healthcare Solutions, Inc.
$64
SERVIER PHARMACEUTICALS LLC
$61
Janssen Biotech, Inc.
$54
TerSera Therapeutics LLC
$54
ABBVIE INC.
$53
Stemline Therapeutics Inc.
$53
Blueprint Medicines Corporation
$52
Karyopharm Therapeutics Inc.
$48
SpringWorks Therapeutics, Inc.
$48
TAIHO ONCOLOGY, INC.
$48
Kite Pharma, Inc.
$47
E.R. Squibb & Sons, L.L.C.
$45
ARRAY BIOPHARMA INC
$41
Adaptive Biotechnologies Corporation
$38
Ipsen Biopharmaceuticals, Inc
$37
Geron Corporation
$34
Amneal Pharmaceuticals LLC
$32
Mirati Therapeutics, Inc.
$30
Alexion Pharmaceuticals, Inc.
$23
Tempus AI, Inc
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
Aveo Pharmaceuticals, Inc.
$20
RECORDATI_RARE_DISEASES_INC.
$18
Agios Pharmaceuticals, Inc.
$18
Sumitomo Pharma America, Inc.
$17
Fennec Pharmaceuticals, Inc.
$17
Iovance Biotherapeutics, Inc.
$17
Genmab U.S., Inc.
$14
ADC Therapeutics America, Inc.
$14
Top 3 companies account for 20.0% of 2024 payments
All-time payments by company (2018-2024) ›
Eisai Inc.
$570
Novartis Pharmaceuticals Corporation
$553
Merck Sharp & Dohme LLC
$536
AstraZeneca Pharmaceuticals LP
$472
Takeda Pharmaceuticals U.S.A., Inc.
$414
Incyte Corporation
$370
PFIZER INC.
$356
Daiichi Sankyo Inc.
$355
Celgene Corporation
$290
Genentech USA, Inc.
$284
Astellas Pharma US Inc
$277
Gilead Sciences, Inc.
$260
Lilly USA, LLC
$234
BeiGene USA, Inc.
$231
Amgen Inc.
$220
Seagen Inc.
$216
EISAI INC.
$213
EMD Serono, Inc.
$211
GENZYME CORPORATION
$202
JAZZ PHARMACEUTICALS INC.
$194
Janssen Biotech, Inc.
$184
Ipsen Biopharmaceuticals, Inc
$181
Regeneron Healthcare Solutions, Inc.
$174
Karyopharm Therapeutics Inc.
$166
SOBI, INC
$143
E.R. Squibb & Sons, L.L.C.
$143
GlaxoSmithKline, LLC.
$141
ARRAY BIOPHARMA INC
$136
Alexion Pharmaceuticals, Inc.
$134
TerSera Therapeutics LLC
$122
Taiho Oncology, Inc.
$119
Stemline Therapeutics Inc.
$112
SEAGEN INC.
$100
Pharmacyclics LLC, An AbbVie Company
$99
Merck Sharp & Dohme Corporation
$97
SERVIER PHARMACEUTICALS LLC
$95
Exelixis Inc.
$91
Pharmacosmos Therapeutics Inc.
$86
Coherus Biosciences Inc.
$83
Blueprint Medicines Corporation
$70
Agios Pharmaceuticals, Inc.
$69
TAIHO ONCOLOGY, INC.
$68
Adaptive Biotechnologies Corporation
$67
Rigel Pharmaceuticals, Inc.
$65
Kite Pharma, Inc.
$60
G1 Therapeutics, Inc.
$59
CTI BioPharma Corp.
$57
ADC Therapeutics America, Inc.
$56
AMAG Pharmaceuticals, Inc.
$53
ABBVIE INC.
$53
Aveo Pharmaceuticals, Inc.
$52
Mirati Therapeutics, Inc.
$51
Amneal Pharmaceuticals LLC
$51
SpringWorks Therapeutics, Inc.
$48
Acceleron Pharma, Inc.
$47
Sun Pharmaceutical Industries Inc.
$45
Genmab U.S., Inc.
$44
Pharmacyclics LLC, an AbbVie Company
$43
EUSA Pharma (US) LLC
$38
RECORDATI_RARE_DISEASES_INC.
$38
Bayer Healthcare Pharmaceuticals Inc.
$35
AVEO Pharmaceuticals, Inc.
$35
Seattle Genetics, Inc.
$34
Geron Corporation
$34
Sumitomo Pharma America, Inc.
$31
TESARO, Inc.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Dendreon Pharmaceuticals LLC
$28
Foundation Medicine, Inc.
$26
Kyowa Kirin, Inc.
$26
Dova Pharmaceuticals
$25
Deciphera Pharmaceuticals Inc.
$23
Tempus AI, Inc
$22
Blue Earth Diagnostics Limited
$22
MENARINI SILICON BIOSYSTEMS, INC.
$22
PharmaEssentia USA Corporation
$21
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
AbbVie, Inc.
$21
Pharming Healthcare, Inc.
$20
Innate Pharma, Inc
$19
Spectrum Pharmaceuticals Inc.
$17
Mylan Pharmaceuticals Inc.
$17
Fennec Pharmaceuticals, Inc.
$17
Iovance Biotherapeutics, Inc.
$17
TOLMAR Pharmaceuticals, Inc.
$15
ImmunoGen, Inc.
$15
Secura Bio, Inc.
$15
Servier Pharmaceuticals LLC
$14
MEDIVATION FIELD SOLUTIONS LLC
$13
Heron Therapeutics, Inc.
$13
Helsinn Therapeutics (U.S.), Inc.
$13
Puma Biotechnology, Inc.
$13
Lexicon Pharmaceuticals, Inc.
$11
Clovis Oncology, Inc.
$9
Top 3 companies account for 15.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALUNBRIG · ASPARLAS · AVASTIN · AYVAKIT · Alecensa · Amtagvi · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cellsearch · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELITEK · ELZONRIS · ENHERTU · EPKINLY · ERLEADA · EXKIVITY · Elahere · Enhertu · Epkinly · FARESTON · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Fulphila · GAZYVA · GILOTRIF · Gavreto · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lumoxiti · Lunsumio · MONJUVI · MONOFERRIC · NINLARO · Nerlynx · Neulasta · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · ORGOVYX · OXBRYTA · Odomzo · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POSLUMA · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Perjeta · Pomalyst · QINLOCK · REBLOZYL · ROLVEDON · RUCONEST · RYBREVANT · RYTELO · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SYLVANT · SYNAGIS · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TEPMETKO · TIBSOVO · TUKYSA · Tavalisse · Tazverik · Tibsovo · Tivdak · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VERZENIO · VONJO · VOTRIENT · VYXEOS · Venclexta · Vonjo · Voranigo · Vyloy · XALKORI · XGEVA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZIIHERA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
70
County median income
$73,795
Nearest hospital to ZIP centroid (approximate)
RIVER VISTA HEALTH AND WELLNESS LLC
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Segal is a mixed practice specialist, with above-average Medicare volume (top 20% in OH), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Segal experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Segal performed 2,857 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Segal receive payments from pharmaceutical companies?
Yes. Dr. Segal received a total of $10,726 from 94 companies across 555 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Segal's costs compare to other medical oncologists in Columbus?
Dr. Segal's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Segal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Columbus
Browse medical oncologists in Columbus ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in OH
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in OH
Which OH medical oncologists receive the most from drug and device companies.
By company
Eisai Inc. Payments to Doctors
See all physicians who received payments from Eisai Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology